Podcast

Share

Program Content

Activities

  • FAQ: Immunotherapy in SCLC
    Immunotherapy in SCLC: FAQ on Current Best Practice and Emerging Therapeutic Strategies
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 27, 2020

    Expires: August 26, 2021

Provided by

ProCE Banner

Supporters

Genentech, a member of the Roche Group

Merck Sharp & Dohme Corp.